Irritable Bowel Syndrome Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are male or female, aged between 18 and 70 years old
- You have been diagnosed with Irritable Bowel Syndrome (IBS) with diarrhoea or mixed bowel habits, based on having stomach pain or discomfort at least 3 days per month for the last 3 months, with symptoms starting at least 6 months ago, plus at least two of these: symptoms improve after going to the toilet, symptoms started when your bowel movements became more or less frequent, or symptoms started when your stool became harder or looser
- Alternatively, you experience loose or watery stools (without pain) in at least 75% of your bowel movements for at least 3 months over the past 6 months (known as functional diarrhoea)
- You have had a colonoscopy (a camera examination of the bowel) within the last 5 years with a normal result
- You are able to read and fill in questionnaires
- You are willing to give written consent to take part in the study
Who may not be able to join:
- You have been diagnosed with conditions such as inflammatory bowel disease, lactose intolerance, coeliac disease, diabetes, thyroid problems, cancer, immune system disorders, autoimmune diseases, or severe liver or kidney problems
- You have had surgery on your small or large intestine, or have had your appendix, womb, or gallbladder removed in the last 6 months
- You have a severe mental illness, or your psychiatric medication type or dose has changed in the last 3 months (confirm with trial site)
- You currently have an active infection
- You have used prebiotics, probiotics, antibiotics, or anti-inflammatory drugs in the last 2 weeks
- You are currently pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yeong Yeh Lee, Universiti Sains Malaysia
Phone: +601161203432
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The improvement of IBS severity using IBS severity scoring system (IBS-SSS) at month 3 after taking SMT04 Pro.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.